Abstract
Neuronal progenitor cells (NPCs) possess high potential for use in regenerative medicine. To overcome their limited mitotic competence, various immortalization strategies have been applied that allow their prolonged maintenance and expansion in vitro. Such immortalized cells can be used for the design and discovery of new cell-based therapies for neurodegenerative diseases, such as Parkinson’s disease. We immortalized rat ventral mesencephalic NPCs by using SV40 large T antigen (SV40Tag). All cell clones displayed a two- to three–fold higher proliferation rate compared with the primary cells. In order to induce dopaminergic differentiation of generated cell clones, both glial-derived neurotrophic factor and di-butyryl cyclic adenosine monophosphate were applied. Treated cells were then characterized regarding the expression of dopaminergic lineage markers, differentiation of various cell populations, calcium imaging in the presence of kainate, and immunohistochemistry after intrastriatal transplantation. Treated cells displayed morphological maturation, and calcium imaging revealed neuronal properties in the presence of kainate. These cells also expressed low mRNA levels of the dopamine transporter and tyrosine hydroxylase (TH), although no TH-immunopositive neurons were found. Intrastriatal transplantation into the neurotoxin-lesioned rats did not induce further differentiation. As an alternative approach, we silenced SV40Tag with short interfering RNA, but this was not sufficient to trigger differentiation into dopaminergic neurons. Nevertheless, neuronal and glial cells were detected as shown by β-tubulin type III and glial fibrillary acidic protein staining, respectively. SV40Tag cells are suitable for carrying out controlled genetic modifications as shown by overexpression of enhanced green fluorescence protein after efficient non-viral transfection.
Similar content being viewed by others
Abbreviations
- AMPA:
-
α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
- BDNF:
-
brain-derived neurotropic factor
- cAMP:
-
di-butyryl cyclic adenosine monophosphate
- DA:
-
dopamine
- DAPI:
-
4,6-diamidino-2-phenylindole
- DAT:
-
dopamine transporter
- EGFP:
-
enhanced green fluorescence protein
- E12:
-
embryonic day 12
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- GDNF:
-
glial cell line-derived neurotrophic factor
- GFAP:
-
glial fibrillary acidic protein
- KA:
-
kainate
- NPCs:
-
neuronal progenitor cells
- PD:
-
Parkinson’s disease
- PFA:
-
paraformaldehyde
- SDS:
-
sodium dodecyl sulfate
- SV40:
-
simian virus 40
- Tag:
-
large T antigen
- TH:
-
tyrosine hydroxylase
- VM:
-
ventral mesencephalic
- 6-OHDA:
-
6-hydroxydopamine
References
Abeliovich A, Hammond R (2007) Midbrain dopamine neuron differentiation: factors and fates. Dev Biol 304:447–454
Adams F, La Rosa F, Kumar S, Edwards-Prasad J, Kentroti S, Vernadakis A, Freed C, Prasad K (1996) Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem Res 21:619–627
Ahuja D, Saenz-Robles MT, Pipas JM (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729–7745
Alexopoulou A, Couchman J, Whiteford J (2008) The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9:2 (doi:10.1186/1471-2121-9-2)
Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J (2006) Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393–405
Bergen J, Park I, Horner P, Pun S (2008) Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 25:983–998
Björklund H, Dahl D, Haglid K, Rosengren L, Olson L (1983) Astrocytic development in fetal parietal cortex grafted to cerebral and cerebellar cortex of immature rats. Brain Res 285:171–180
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Bjorklund A, Brooks DJ, David Marsden C, Oertel WH, Quinn NP, Rehncrona S, Lindvall O (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson’s disease. Brain 123:1380–1390
Cantalupo P, Sáenz-Robles M, Rathi A, Beerman R, Patterson W, Whitehead R, Pipas J (2009) Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology 386:183–191
Carriedo SG, Sensi SL, Yin HZ, Weiss JH (2000) AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20:240–250
Cesnulevicius K, Timmer M, Wesemann M, Thomas T, Barkhausen T, Grothe C (2006) Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells 24:2776–2791
Chakrabarty K, Serchov T, Mann SA, Dietzel ID, Heumann R (2007) Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones. Eur J Neurosci 25:1971–1981
Clarkson E, La Rosa F, Edwards-Prasad J, Kumar S, Kumar A, Cole W, Freed C, Prasad K (1998) Brain contains inhibiting factors specific to the large T-antigen gene. Cancer Lett 122:31–36
Grosskreutz J, Haastert K, Dewil M, Van Damme P, Callewaert G, Robberecht W, Dengler R, Van Den Bosch L (2007) Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium 42:59–69
Hoshimaru M, Ray J, Sah D, Gage F (1996) Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 93:1518–1523
Hyman C, Hofer M, Barde Y, Juhasz M, Yancopoulos G, Squinto S, Lindsay R (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232
Jat PS, Sharp PA (1989) Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol Cell Biol 9:1672–1681
König N, Poluch S, Estabel J, Durand M, Drian M, Exbrayat J (2001) Synaptic and non-synaptic AMPA receptors permeable to calcium. Jpn J Pharmacol 86:1–17
La Rosa F, Adams F, Krause G, Meyers A, Edwards-Prasad J, Kumar R, Freed C, Prasad K (1997) Inhibition of proliferation and expression of T-antigen in SV40 large T-antigen gene-induced immortalized cells following transplantations. Cancer Lett 113:55–60
Legrand A, Nachtigal M (1991) Homologous recombination of a plasmid containing the SV40 early region in rabbit cells. Intervirology 32:173–184
Lindholm P, Voutilainen M, Laurén J, Peränen J, Leppänen V, Andressoo J, Lindahl M, Janhunen S, Kalkkinen N, Timmusk T, Tuominen R, Saarma M (2007) Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448:73–77
Lindvall O, Kokaia Z (2009) Prospects of stem cell therapy for replacing dopamine neurons in Parkinson’s disease. Trends Pharmacol Sci 30:260–267
Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277:38884–38894
McNees A, White Z, Zanwar P, Vilchez R, Butel J (2005) Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 34:52–62
Miljan EA, Hines SJ, Pande P, Corteling RL, Hicks C, Zbarsky V, Umachandran M, Sowinski P, Richardson S, Tang E, Wieruszew M, Patel S, Stroemer P, Sinden JD (2009) Implantation of c-mycERTAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson’s disease. Stem Cells Dev 18:307–320
Molteni R, Ying Z, Gómez-Pinilla F (2002) Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 16:1107–1116
Nikkhah G, Cunningham M, Jödicke A, Knappe U, Björklund A (1994a) Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633:133–143
Nikkhah G, Olsson M, Eberhard J, Bentlage C, Cunningham M, Björklund A (1994b) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63:57–72
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199
Ostenfeld T, Caldwell M, Prowse K, Linskens M, Jauniaux E, Svendsen C (2000) Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 164:215–226
Paul G, Christophersen N, Raymon H, Kiaer C, Smith R, Brundin P (2007) Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line—studies in vitro and after intracerebral grafting in vivo. Mol Cell Neurosci 34:390–399
Peterson A, Nutt J (2008) Treatment of Parkinson’s disease with trophic factors. Neurotherapeutics 5:270–280
Prasad K, Carvalho E, Kentroti S, Edwards-Prasad J, Freed C, Vernadakis A (1994) Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol Anim 30A:596–603
Ray F, Peabody D, Cooper J, Cram L, Kraemer P (1990) SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 42:13–31
Raye WS, Tochon-Danguy N, Pouton CW, Haynes JM (2007) Heterogeneous population of dopaminergic neurons derived from mouse embryonic stem cells: preliminary phenotyping based on receptor expression and function. Eur J Neurosci 25:1961–1970
Simon HH, Bhatt L, Gherbassi D, Sgadó P, Alberí L (2003) Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann N Y Acad Sci 991:36–47
Smidt M, Burbach J (2007) How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8:21–32
Southern P, Berg P (1982) Transformation of mammalian cells to antibiotic resistent with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1:327–341
Stubdal H, Zalvide J, DeCaprio JA (1996) Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J Virol 70:2781–2788
Studer L, Tabar V, McKay R (1998) Transplantation of expanded mesencephalic precursors leads to recovery in Parkinsonian rats. Nat Neurosci 1:290–295
Takayama H, Ray J, Raymon H, Baird A, Hogg J, Fisher L, Gage F (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson’s disease. Nat Med 1:53–58
Timmer M, Müller-Ostermeyer F, Kloth V, Winkler C, Grothe C, Nikkhah G (2004) Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp Neurol 187:118–136
Timmer M, Grosskreutz J, Schlesinger F, Krampfl K, Wesemann M, Just L, Bufler J, Grothe C (2006) Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol Dis 21:587–606
Tomac A, Lindqvist E, Lin L, Ogren S, Young D, Hoffer B, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335–339
Truckenmiller ME, Tornatore C, Wright RD, Dillon-Carter O, Meiners S, Geller HM, Freed WJ (1998) A truncated SV40 large T antigen lacking the p53 binding domain overcomes p53-induced growth arrest and immortalizes primary mesencephalic cells. Cell Tissue Res 291:175–189
Vandenberghe W, Robberecht W, Brorson JR (2000) AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci 20:123–132
Villa A, Liste I, Courtois E, Seiz E, Ramos M, Meyer M, Juliusson B, Kusk P, Martínez-Serrano A (2009) Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res 315:1860–1874
Volpicelli F, Perrone-Capano C, Da Pozzo P, Colucci-D’Amato L, Porzio U di (2004) Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones. J Neurochem 88:1283–1294
Winkler C, Kirik D, Björklund A, Dunnett S (2000) Transplantation in the rat model of Parkinson’s disease: ectopic versus homotopic graft placement. Prog Brain Res 127:233–265
Winkler C, Kirik D, Björklund A, Cenci M (2002) L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson’s disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10:165–186
Acknowledgements
We thank the Department of Experimental Nephrology (Hannover Medical School) for permission to use the Amaxa Nucleofector device. We gratefully acknowledge the generous gift of the pCAGGS-EGFP vector from Dr. J.R. Whiteford. We also thank Kerstin Kuhlemann, Hella Brinkmann, Natascha Heidrich, and Silke Fischer for excellent technical support and Jürgen Wittek, Serguei Tkachuk, Kerstin Schwabe, and Johannes Haile for discussions.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by EU Marie Curie host fellowships (A.N.) for early stage researchers training—MEST-CT-2005-021 014 (“ZSN-PHD Program”) and by Georg-Christoph-Lichtenberg scholarships (I.K., K.C., and D.R.) provided by the Ministry of Science and Culture of Lower Saxony, as part of the international PhD program of the Center for Systems Neuroscience Hannover, Germany.
An erratum to this article can be found at http://dx.doi.org/10.1007/s00441-010-0999-z
Rights and permissions
About this article
Cite this article
Nobre, A., Kalve, I., Cesnulevicius, K. et al. Characterization and differentiation potential of rat ventral mesencephalic neuronal progenitor cells immortalized with SV40 large T antigen. Cell Tissue Res 340, 29–43 (2010). https://doi.org/10.1007/s00441-010-0933-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-010-0933-4